Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Cardiovascular / Cardiology News

European mutual recognition procedure approves 32 mg dose for Atacand®

Main Category: Cardiovascular / Cardiology
Article Date: 13 Aug 2004 - 15:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

AstraZeneca today announced that the European Mutual Recognition Procedure (MRP) for a 32 mg tablet of its important antihypertensive drug Atacand® (candesartan cilexetil) has been completed. The UK was the Reference Member State for the European Mutual Recognition Procedure for marketing approval across other EU countries*.

Clinical studies have shown that once daily Atacand® has a dose-related antihypertensive effect over the entire dose range to 32 mg1. The extensive data indicate that, particularly in hypertensive patients who are not adequately controlled with Atacand® 16 mg once daily, a dose increase to 32 mg results in additional blood pressure reduction2. The 32 mg dose of Atacand® has been available in the US since 1998.

The higher dose of 32 mg was the target dose in the CHARM* Programme, evaluating Atacand® in heart failure, for which AstraZeneca submitted a European regulatory application in April this year. The submission followed the positive results of the CHARM Programme, first presented at the European Society of Cardiology in August 2003. CHARM proved Atacand® to be the first AT1-receptor blocker to reduce both cardiovascular deaths and hospital admissions for heart failure, across a broad spectrum of patients with chronic heart failure3.

Gunnar Olsson, VP and Head of the Cardiovascular Therapy Area, said: "This is an important step in the use of Atacand® in the treatment of hypertension, and will mean that physicians have an additional treatment option available when deciding how best to manage patients, particularly where monotherapy is favoured over combination therapy."

Contact information

Elizabeth Rickard - Ketchum Mobile: +44 7786 246 618 Office: +44 20 7611 3633
Email: elizabeth.rickard@ketchum.com

Anette Orheim - Mobile: +46 709 13 19 52 Office: +46 46 33 80 87
Email: anette.orheim@astrazeneca.com

Stephanie Gardner - Ketchum, London office Office: +44 20 7611 3510 Mobile: +44 7779 300 685
Email: stephanie.gardner@ketchum.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Pulmonary Edema? What Causes Pulmonary Edema?
15 Oct 2009
Pulmonary edema (UK/Ireland: oedema) is fluid accumulation in the lungs. This fluid collects in air sacs in the lungs, making it difficult to breathe. It leads to impaired gas exchange and may cause respiratory failure...


Stress and Sports image Stress and Sports

Many people turn to sports to unwind, but the pressure of competition can turn otherwise relaxing pursuits into sources of stress (and affect your game, too). Our panel of experts will discuss what you can do to make sure your sports life helps, rather than hurts, your state of mind...

Life After a Heart Transplant image Life After a Heart Transplant

Heart transplant success is determined by your post-surgery quality of life. Successful patients are able to resume activities they enjoyed before the procedure, such as moderate exercise and sexual activity. Join Dr. Mehmet Oz and ex-baseball star and donor-heart recipient Frank Torre, as they...

View more videos...